Biotech

All Articles

Biogen's CEO claimed no unsafe handle 2023. He's ready to be vibrant

.While Biogen's pharma peers are seeking for late-stage resources along with little bit of threat, c...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Bio has actually been a biotech looking for a pipeline after it junked its own lead possessi...

Biogen walks away from Denali Alzheimer's collab

.Biogen has returned civil rights to an early Alzheimer's illness system to Denali Therapeutics, lea...

Takeda taps new mind people oncology business-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of considerable management hirings, firings a...

Vertex, hammered by AATD again, loses 2 properties on throw away stack

.Vertex's try to alleviate a rare genetic disease has hit one more misfortune. The biotech shook two...

Vir increases 3 T-cell engagers coming from Sanofi, gives up 25% of workers

.Vir Biotechnology's second-quarter revenues file had not been except big news. The business invited...

Galapagos pauses CAR-T tissue treatment litigation over Parkinsonism scenario

.Galapagos has stopped briefly enrollment in a test of a BCMA-directed CAR-T tissue therapy, pumping...

James Wilson leaving behind Penn to launch two brand new biotechs

.After greater than 30 years, genetics therapy pioneer James Wilson M.D., Ph.D., is leaving the Coll...

3 biotechs attempt to beat the summer season heat by dropping workers

.As biotechs attempt to switch a fresh page in August, at least 3 providers have actually lost perso...

venBio lifts $528M for fifth lifestyle sciences VC fund

.Expert venture capital organization venBio has actually elevated one more half a billion dollars to...